Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FX3M9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,842
Award facts
- Contract value 100% obligated
- $42,842.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $42,842.20 to AmerisourceBergen Drug Corp for Beyfortus 100 mg/ml syringes on November 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 10, 2025. This delivery order is a child contract action issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its DLA prime vendor agreement, which enables the company to supply a broad range of medications, vaccines, and medical supplies to support Department of Defense health programs globally. Beyfortus, a respiratory syncytial virus (RSV) monoclonal antibody immunization product, represents one of the specialized pharmaceutical commodities the company provides through its federal procurement contracts. The firm fixed pricing and rapid completion timeline reflect the streamlined procurement processes available through DLA's established pharmaceutical supply chain, allowing for efficient delivery of essential medical products to military healthcare facilities.
Quick answers
Who was awarded contract SPE2DR26FX3M9?
SPE2DR26FX3M9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FX3M9 worth?
The government has obligated $42,842 on SPE2DR26FX3M9.
Is contract SPE2DR26FX3M9 an order under another contract?
Yes. SPE2DR26FX3M9 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX3M9 competed?
The extent of competition for SPE2DR26FX3M9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award